TM
Milk & Dairy Beef Drug Residue Prevention
REFERENCE MANUAL 2018 TM
National Milk Producers Federation (NMPF) does not endorse any of the veterinary drugs or tests identified on the lists in this manual. The lists of veterinary drugs and tests are provided only to inform producers and veterinarians what products may be available, and the producer and veterinarian are responsible for determining whether to use any of the veterinary drugs or tests. All information regarding the veterinary drugs or tests was obtained from the products’ manufacturers or sponsors, and NMPF has made no further attempt to validate or corroborate any of that information. NMPF urges producers to consult with their veterinarians before using any veterinary drug or test, including any of the products identified on the lists in this manual. In the event that there might be any injury, damage, loss or penalty that results from the use of these products, the manufacturer of the product or the producer using the product shall be responsible. NMPF is not responsible for, and shall have no liability for, any injury, damage, loss or penalty.
© 2018 National Milk Producers Federation
This manual is not a legal document and is intended for educational purposes only. Dairy farmers are individually responsible for determining and complying with all requirements of local, state and federal laws and regulations regarding animal care.
2 PRODUCT INFORMATION NADA 141-299, Approved by FDA.
(Florfenicol and Flunixin Meglumine) Antimicrobial/Non-Steroidal Anti-Inflammatory Drug For subcutaneous use in beef and non-lactating dairy cattle only. Not for use in female dairy cattle 20 months of age or older or in calves to be processed for veal. BRIEF SUMMARY: For full prescribing information, see package insert. INDICATION: RESFLOR GOLD® is indicated for treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma bovis, and control of BRD-associated pyrexia in beef and non-lactating dairy cattle. CONTRAINDICATIONS: Do not use in animals that have shown hypersensitivity to florfenicol or flunixin. WARNINGS: NOT FOR HUMAN USE. KEEP OUT OF REACH OF CHILDREN. This product contains material that can be irritating to skin and eyes. Avoid direct contact with skin, eyes, and clothing. In case of accidental eye exposure, flush with water for 15 minutes. In case of accidental skin exposure, wash with soap and water. Remove contaminated clothing. Consult a physician if irritation persists. Accidental injection of this product may cause local irritation. Consult a physician immediately. The Material Safety Data Sheet (MSDS) contains more detailed occupational safety information. For customer service or to obtain a copy of the MSDS, call 1-800-211-3573. For technical assistance or to report suspected adverse reactions, call 1-800-219-9286. Not for use in animals intended for breeding purposes. The effects of florfenicol on bovine reproductive performance, pregnancy, and lactation have not been determined. Toxicity studies in dogs, rats, and mice have associated the use of florfenicol with testicular degeneration and atrophy. NSAIDs are known to have potential effects on both parturition and the estrous cycle. There may be a delay in the onset of estrus if flunixin is administered during the prostaglandin phase of the estrous cycle. The effects of flunixin on imminent parturition have not been evaluated in a controlled study. NSAIDs are known to have the potential to delay Knock out BRD and take down the fever that usually comes with it when you use parturition through a tocolytic effect. Resflor Gold® (florfenicol and flunixin meglumine). The only major antibiotic to combine RESFLOR GOLD®, when administered as directed, the BRD-treating action of florfenicol with the symptom-fighting action of flunixin. With may induce a transient reaction at the site of injection one shot, Resflor Gold makes your animals feel better within six hours.1,2 So they aren’t and underlying tissues that may result in trim loss of just back on their feet eating and drinking, they’re back on track. Talk to your Merck edible tissue at slaughter. Animal Health rep or visit resflorgold.com to learn more. RESIDUE WARNINGS: Animals intended for human consumption must not be slaughtered within 38 days of treatment. Do not use in female dairy cattle 20 months of age or older. Use of florfenicol in this class of cattle may cause milk residues. A withdrawal period has not been established in pre-ruminating calves. Do not use in calves to be processed for veal. IMPORTANT SAFETY INFORMATION NOT FOR HUMAN USE. KEEP OUT OF REACH OF CHILDREN. This product contains material that can be irritating to skin and eyes. Animals intended for human consumption must not be slaughtered within ADVERSE REACTIONS: Transient inappetence, 38 days of treatment. This product is not approved for use in female dairy cattle 20 months of age or older, including diarrhea, decreased water consumption, and injection dry dairy cows. Use in these cattle may cause drug residues in milk and/or in calves born to these cows. A withdrawal site swelling have been associated with the use of period has not been established in preruminating calves. Do not use in calves to be processed for veal. Do not use florfenicol in cattle. In addition, anaphylaxis and collapse have been reported post-approval with the in animals that have shown hypersensitivity to florfenicol or flunixin. Not for use in animals intended for breeding use of another formulation of florfenicol in cattle. purposes. The effects of florfenicol and flunixin on bovine reproductive performance, pregnancy, and lactation have not been determined. When administered according to the label directions, RESFLOR GOLD may induce a transient In cattle, rare instances of anaphylactic-like reactions, local reaction in the subcutaneous and underlying muscle tissue. some of which have been fatal, have been reported, primarily following intravenous use of flunixin 1 Exhibits bactericidal activity against some strains of Mannheimia haemolytica and Histophilus somni. meglumine. 2 The correlation between in vitro susceptibility data and clinical effectiveness is unknown. merck-animal-health-usa.com • 800-521-5767 Copyright ©2017 Intervet Inc., doing business as Merck Animal Health, a subsidiary of Merck & Co., Inc. All rights reserved. Made in Germany 9/17 BV-RG-56197-D Intervet Inc. Roseland, NJ 07068 ©2009, Intervet Inc. All Rights Reserved. 3 May 2009 US 3448_IV Foreword
The goal of our nation’s dairy farmers is to protocols that ensure that antimicrobials are produce the best tasting and most wholesome used correctly. Once a decision is made to use milk possible. Our consumers demand the best antimicrobials, then protocols must be in place from us and we meet their needs and exceed to guide employees on the safe way to handle the their expectations every day. Day in and day animal to prevent an inadvertent milk or meat out, our dairy farmers provide the best in animal residue from occurring. Identification of treated husbandry. Continually, we evaluate our best animals and recording drug use are essential management practices and disease prevention to prevent residues. For nearly 30 years, each protocols to keep our animals healthy and revision of the Milk & Dairy Beef Drug Residue comfortable. There are occasions when animals Prevention Reference Manual has served as the may get sick and need antimicrobial therapy to U.S. dairy industry’s commitment to antimicrobial overcome a specific disease challenge. As dairy stewardship – the judicious and responsible use of producers, we strategically and judiciously use our antibiotics and other drugs in dairy animals. This antimicrobial therapy to help an individual animal year’s revised manual is a quick resource to review that has been threatened with a disease. those drugs approved for dairy animals and can also be used as an educational tool and resource We take this responsibility of judicious for farm managers as they develop on-farm best antimicrobial use seriously and take many management practices. I encourage all dairy precautions with our antibiotic-treated animals farmers to sit down with their veterinarians and so that their milk or meat does not enter the employees to review this manual as you will food supply. The avoidance of milk and meat find the information useful, practical and easily residues in the dairy industry takes an on-farm applied to your individual farms. team effort that begins with the VCPR – the Veterinarian-Client-Patient Relationship. Dairy farm owners/managers/herdsman must work with their veterinarians to develop treatment
Sincerely,
Karen Jordan, DVM Dairy Producer Chair – NMPF Animal Health and Well-being Committee
4 Foreword Table of Contents
Chapter 1: Introduction 6 Lactating Cows • Antimicrobial Stewardship 8 • Injectable Use 40 • Animal Drugs 8 • Intramammary Use 41 • Milk Drug Residue Testing 11 • Oral Use 41 • Multi-Drug Screening Test • Feed Additive Use 42 for Bulk Tank Milk 11 • Intravaginal Administration 42 • Meat Drug Residue Testing 12 • Topical Use 42 • Conditions that Warrant Screening Tests Additional Testing at USDA • Serum and Urine Screening Tests 44 Slaughter Facilities 16 • Milk Screening Tests 49 • Records Management 17 • Test Contact Information 69 Chapter 2: Residue Appendix 70 Overview 20 • Drugs Prohibited from Extra-Label • Considerations for Culling 71 Use in Animals 22 • Pharmaceutical Administration 72 • Drugs Not Approved for Use in Resources 74 Food-Producing Animals 22 • Underlying Causes of Antibiotic Sample Record-Keeping Forms Residues in Milk and Meat 23 • VCPR Form 76 • Potential Residue Violations • 8-Step Plan for Keeping Records 78 from Extra-Label Drug Use • Recommended or Approved in an Unapproved Class of Cattle 24 Drug List 79 • Examples of Products and • Sample Animal Treatment Plan 80 Risk Factors for Residues 27 • Beginning Drug Inventory 81 • Steps to Prevent Drug Residues 28 • Record of Drug Purchases 82 • Best Management Checklist • Daily Treatment Record 83 to Avoid Drug Residues 29 • Drug Disposal Record 84 • Certificate of Review 85 Chapter 3: Approved Drugs & Screening Tests 32 FDA-Approved Drugs Non-Lactating Cattle • Injectable Use 34 • Intramammary Use 35 • Oral Use 36 • Topical Use 37 • Feed Additive Use 38
Table of Contents 5 01Introduction 6 Drug Residue Prevention Reference Manual 2018 The U.S. dairy industry is committed to producing the highest quality, safe, abundant and affordable milk and dairy beef. Healthy animals help make for safe food, and disease prevention is the key to keeping cows healthy. When dairy animals get sick and treatment is necessary, producers and veterinarians utilize antibiotics and other drugs judiciously. Antimicrobials should be used appropriately to prevent residues from occurring in milk and dairy beef. The marketing of milk or dairy beef with drug residues, even unintentionally, is illegal and can result in financial and criminal penalties.
Chapter 1 Introduction 7 Antimicrobial Stewardship diagnosis and quick decision-making on necessary Antimicrobial stewardship goes beyond an treatment of all sick or injured dairy cattle on the individual dairy farmer’s actions. It extends across farm. Even with the best prevention programs, all livestock production, and use of antimicrobials animals can become sick or injured, and judicious in companion animals and humans. Misuse and and responsible use of antimicrobials (including overuse of antimicrobials is one of the world’s antibiotics) under veterinary supervision may be most pressing public health concerns. Infectious necessary to improve the health outcome of the organisms adapt to antimicrobials designed animal. to kill them, making the drugs less effective. The Food and Drug Administration Center for Animal Drugs Veterinary Medicine (FDA CVM) has committed to There are three classes of animal drugs: Over-the- antimicrobial stewardship for use in animals. FDA Counter (OTC), Prescription (Rx) and Veterinary CVM supports several important principles that Feed Directive (VFD). OTC drugs can be sold by are critical to curbing or slowing the emergence of any person or establishment without a veterinary antimicrobial resistance. With respect to veterinary prescription. Rx drugs can only be sold to the settings, these principles are: 1) antimicrobial producer by a veterinarian or pharmacist, and drugs should only be used when necessary to only with a veterinary prescription. VFD is a drug treat, prevent or control disease, and 2) when intended for use in or on feed, which is limited antimicrobials are used, these drugs should be by an approved application to use under the administered in an optimal manner under the professional supervision of a licensed veterinarian. supervision of a licensed veterinarian. Pulmotil® (tilmicosin) is the first VFD product approved for use in cattle. The FDA approved the To further advance antimicrobial stewardship, FDA drug as a treatment for groups of cattle in the early CVM is focusing on three key initiatives over the stages of a bovine respiratory disease outbreak course of the next five years: (1) Align antimicrobial to provide 14 days of sustained in-feed therapy. drug products with the principles of antimicrobial Pulmotil® is approved for use in beef and non- stewardship in veterinary settings, (2) Support lactating dairy cattle. efforts to foster stewardship of antimicrobials in veterinary settings, and (3) Assess the impact In December 2013, the FDA finalized Guidance of strategies intended to curb the emergence of for Industry #213 establishing the procedures antimicrobial resistance associated with the use of for voluntarily phasing out growth promotion antimicrobial drugs in veterinary settings. indications for medically important antibiotics in alignment with Guidance for Industry #209. In combination, the National Dairy FARM Program’s In June 2015, the FDA finalized the Veterinary Animal Care Reference Manual and the Milk & Dairy Feed Directive (VFD) to improve efficiency of the Beef Drug Residue Prevention Reference Manual program. The VFD regulation mandates the rules serve as the roadmap for the U.S. dairy industry’s and responsibilities of licensed veterinarians in commitment to antimicrobial stewardship. That prescribing and administering medically important commitment begins on the farm with coordinated antibiotics in feed or water. A licensed veterinarian animal health and care programs, including a must have an established Veterinarian-Client- Herd Health Plan developed in consultation with Patient Relationship to prescribe a VFD drug. The the Veterinarian of Record. An effective written final VFD rules also prohibit any “extra-label drug Herd Health Plan emphasizes prevention, rapid use” so a VFD prescription must conform exactly to
8 Drug Residue Prevention Reference Manual 2018 the drug manufacturer’s label indications, including in lactating and dry cows or as coccidiostats in the specific disease or condition being treated. growing heifers. There are no legal extra-label uses of VFD drugs. Any use of a drug not specifically listed on the label is called “extra-label drug use” and is regulated With these guidances and VFD changes, animal by the FDA under the Animal Medicinal Drug pharmaceutical companies agreed to voluntarily Use Clarification Act (AMDUCA) of 1994. Using revise the FDA-approved use conditions for these a prescription or over-the-counter drug in an products to remove production indications through extra-label manner is illegal unless it is specifically feed by December 31, 2016. The over-the-counter prescribed with withdrawal times by a veterinarian status for the remaining approved therapeutic uses working in the context of a Veterinarian-Client- through feed now require a VFD under veterinary Patient Relationship (VCPR). oversight as of the same date. Additionally, water- soluble drugs, such as those administered through Examples of extra-label drug use: milk replacer, were scheduled to transition from • Changing the dose, such as giving more penicillin OTC to prescription on that date. There are no than is listed on the label VFD drugs approved for use in lactating dairy • Changing the route of administration, such cattle. as giving flunixin intramuscularly (IM) or subcutaneously (SQ) instead of intravenously (IV) FDA Guidance for Industry #152 defines medically • Giving a drug to a different production class of important antibiotics that will be subject to the animal, such as using Nuflor® in a lactating dairy VFD when administered in feed or water to include cow aminoglycosides, lincosamides, macrolides, • Giving a drug for an indication (disease) not listed penicillins, streptogramins, sulfonamides and on the label, such as using Excede® for diarrhea tetracyclines. Ionophores, like monensin, are • Changing the withholding times, such as not not affected by the guidance, since they have no following milk withholding times for fresh cows human medical relevance. Thus, the actions have after dry treatment administration no effect on the use of ionophore additives • Changing the amount of drug per injection site • Changing the duration of therapy
Chapter 1 Introduction 9 2016 A THE BEEF
COW NBMARKET LL & BU ABOUT DAIRY
airy cattle make up a significant segment to the beef industry. stories. Additional research was conducted in 2017 to determine DIn fact, cull breeding animals of all types, including dairy, the presence of injection site lesions in the round (hind leg) are estimated to contribute about 20 percent of operational gross based on a procedure used in previous injection-site audits. revenue to operations. Paying attention to factors impacting that The most recent research demonstrated a 20 percentage point revenue makes good business sense. Realizing how important reduction in lesions during the past 15 years in dairy-type carcasses these cattle are, the beef industry conducted its first market cow (Figure 2). Although this is a win for the dairy industry, it is vital and bull beef quality audit in 1994. That audit assessed quality that producers continue to adopt and implement BQA practices, strengths and shortfalls of beef from market cows and bulls and particularly administering all injections in the neck unless specified established a benchmark to determine further progress down the on the label. road. The 2016 Market Cow and Bull Beef Quality Audit assessed Figure 2. Incidence of injection-site lesions in the round progress in managing these issues and suggested improvements for further increasing the value and marketability of cows and 80 bulls. Major areas of focus were transportation and cattle mobility, Dairy live animal evaluation, and carcass evaluation. 60 Beef 60 51 Transportation and Cattle Mobility
Since 2007, there has been an impressive 24.6 percentage point increase 40 35 in sound dairy cows (Figure 1). Although the 2016 Market Cow and 31 26 Bull Audit indicated positive findings, it’s important that producers 20 continue to focus on marketing their cattle before lameness is observed 20 15 whenever possible to prevent animal welfare issues. 7
0 Figure 1. Frequency distribution of cattle that were not lame 1998 1999 2000 2017
100 Beef Cows The research also found that there was very little incidence of arthritic Beef Bulls joints. Nearly 99 percent of carcasses were free of arthritic joints, a Dairy Cows nearly 5 percent increase since 2007 and an important improvement Dairy Bulls 89 towards carcass value and an indication of timely culling. 87
84 83 Conclusions There is ample evidence in this research to suggest that there have 78 77 77 been improvements in the market cow and bull beef sector since 76 76
75 73 73 2007—and significant improvement in the quality of carcasses Percentage 71 from dairy cows. Progress can continue, however, by focusing on: 69 • Food safety, an important factor for those who purchase beef;
64 • Appropriate management of cull cows and bulls to increase
60 muscle condition before harvest; • Culling animals before physical defects are severe; • Seeking to better understand causes of liver abscesses; • Implementing measures to eliminate carcass bruising; 51 • Reducing defects to allow the cow and bull industry to 50 1994 1999 2007 2016 capture additional value; and Year • Emphasizing education in the Dairy FARM and BQA programs to propel the momentum of the cow and bull industry.
Live Animal Evaluations For the full Executive Summary and more Body condition scores for dairy cows have improved substantially, information about the 2016 NBQA for from 36 percent to 45 percent having a body condition score of 3 market cows and bulls visit the Beef Quality or above (scale of 1-5 in) in 2016. Reduced numbers of injection Assurance website site lesions through the years is one of the industry’s true success at www.bqa.org. 2016 A THE BEEF Figure 1. Percent of Bulk Milk Tankers Positive For Drug Residues, 1995-2016
COW NBMARKET LL & BU ABOUT DAIRY 0.12%
0.10% Percent of Bulk Milk Tankers airy cattle make up a significant segment to the beef industry. stories. Additional research was conducted in 2017 to determine Positive for Drug Residues DIn fact, cull breeding animals of all types, including dairy, the presence of injection site lesions in the round (hind leg) 0.08% are estimated to contribute about 20 percent of operational gross based on a procedure used in previous injection-site audits. revenue to operations. Paying attention to factors impacting that The most recent research demonstrated a 20 percentage point 0.06% revenue makes good business sense. Realizing how important reduction in lesions during the past 15 years in dairy-type carcasses these cattle are, the beef industry conducted its first market cow (Figure 2). Although this is a win for the dairy industry, it is vital 0.04% and bull beef quality audit in 1994. That audit assessed quality that producers continue to adopt and implement BQA practices, strengths and shortfalls of beef from market cows and bulls and particularly administering all injections in the neck unless specified 0.02% established a benchmark to determine further progress down the on the label. 0.011% road. The 2016 Market Cow and Bull Beef Quality Audit assessed Figure 2. Incidence of injection-site lesions in the round progress in managing these issues and suggested improvements 0.00% for further increasing the value and marketability of cows and 80 2014 2015 2016 2012 2013 Base Data Milk Drug Residue National from Data bulls. Major areas of focus were transportation and cattle mobility, Dairy 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 Year live animal evaluation, and carcass evaluation. 60 Beef 60 51 Transportation and Cattle Mobility Since 2007, there has been an impressive 24.6 percentage point increase 40 35 Milk Drug Residue Testing increased education and industry advancements, in sound dairy cows (Figure 1). Although the 2016 Market Cow and 31 26 The Grade “A” Pasteurized Milk Ordinance (PMO), of the 3,085,627 bulk milk pick-up tankers tested Bull Audit indicated positive findings, it’s important that producers 20 continue to focus on marketing their cattle before lameness is observed 20 15 the rules that state regulatory agencies use to by industry and state regulatory agencies from whenever possible to prevent animal welfare issues. 7 implement their Grade “A” milk programs, requires October 2015 to September 2016, 0.011 percent 0 tested positive for drug residues. This signifies a Figure 1. Frequency distribution of cattle that were not lame 1998 1999 2000 2017 that all bulk milk tankers be sampled and analyzed for beta-lactam drug residues before the milk is dramatic decrease from an already low level of 100 Beef Cows The research also found that there was very little incidence of arthritic processed. For 18 months, beginning July 1, occurrence.2 See Figure 1. Beef Bulls joints. Nearly 99 percent of carcasses were free of arthritic joints, a 2017, milk tank trucks are also being tested Dairy Cows nearly 5 percent increase since 2007 and an important improvement Dairy Bulls for the tetracycline family of drugs. See Page 13. Multi-Drug Screening Test for Bulk 89 towards carcass value and an indication of timely culling. 87 At the conclusion FDA will examine the results and Tank Milk 84 83 Conclusions determine next steps, including the possibility of In 2010, the Food and Drug Administration There is ample evidence in this research to suggest that there have formalizing tetracycline testing requirements. developed a multi-class, multi-residue liquid 78 77 77 been improvements in the market cow and bull beef sector since 76 76 chromatography/tandem mass spectrometry 75 73 73 2007—and significant improvement in the quality of carcasses Percentage The PMO also requires states to test farm-level milk (LC-MS/MS) screening and confirmation method 71 from dairy cows. Progress can continue, however, by focusing on: 69 • Food safety, an important factor for those who purchase beef; samples at least four times every six months for for drug residues in milk. The procedure is detailed 64 • Appropriate management of cull cows and bulls to increase antibiotics (called Section 6 testing). Most states in FDA Laboratory Information Bulletin #4443. 60 muscle condition before harvest; use an “inhibitor” test, which shows sensitivity According to the bulletin’s authors, the intended • Culling animals before physical defects are severe; to any antibiotic in milk. Finally, customers (e.g., purpose of this method is to screen samples to • Seeking to better understand causes of liver abscesses; • Implementing measures to eliminate carcass bruising; processors) may require additional testing for determine if a residue is present at the level of 51 • Reducing defects to allow the cow and bull industry to quality assurance purposes. Any tanker found interest (i.e., target testing/tolerance levels or 50 1994 1999 2007 2016 capture additional value; and positive for any antibiotic residue is rejected for established levels of detection) and also to confirm Year • Emphasizing education in the Dairy FARM and BQA programs human consumption. the identity of the compound. An exact quantitative to propel the momentum of the cow and bull industry. determination of any residue is not addressed Live Animal Evaluations For the full Executive Summary and more In 1996, of the 3,384,779 bulk milk pick-up tankers with this procedure and is obtained using Body condition scores for dairy cows have improved substantially, information about the 2016 NBQA for tested, 0.104 percent tested positive.1 Through other methodology. from 36 percent to 45 percent having a body condition score of 3 market cows and bulls visit the Beef Quality or above (scale of 1-5 in) in 2016. Reduced numbers of injection Assurance website site lesions through the years is one of the industry’s true success at www.bqa.org. Chapter 1 Introduction 11 12 Drug Residue Prevention Reference Manual2018 appropriate production classes,and4)establishing compounds, 3)pairing thesecompounds with concern, 2)using algorithms to rank theselected 1) determining thecompounds are offood safety oftheplanbyUSDAdevelopment FSIS includes: tissue from healthy-appearing food animals.The for thesechemicals through arandom samplingof consumption. TheScheduledSamplingPlantests andegg productsmeat, poultry destined for human drugs, pesticides andenvironmental chemicals –in tests for chemicals –includingantibiotics andother Safety (USDA Inspection Service FSIS) conducts The United States Department ofAgriculture Food Meat DrugResidue Testing modified thismethod to includeadditionaldrugs. tripelennamine. Sometesting laboratories have bacitracin, thiabendazole, virginiamycin and sarafloxacin, enrofloxacin orciprofloxacin, flunixin, tylosin,tilmicosin,doxycycline, erythromycin, oxytetracycline, tetracycline, chlortetracycline, sulfachloropyridazine, sulfamerazine, sulfathiazole, sulfaquinoxaline, sulfapyridine, sulfamethazine, sulfadiazine, sulfadimethoxine, ampicillin, penicillinG,cloxacillin, cephapirin, This method tests for thefollowing drugs:
HIGH RISK LOW RISK Figure 2.TissueResidueof aDairyCow RiskAssessment for Market ☐ to determine status ofanimalbefore off ered for sale.Whenindoubt holditout! If anyoftheabovehigh-riskattributes exist, consult pharmaceutical, orscreening test veterinary experts ☐ ☐
Animal never treatedAnimal never withdrugs
label used isnot asprescribed onthe Route ofadministration that was to person sendingcow to market documented ornot communicated History ofanimaltreatment not Animal isdisplayinglameness,injection sites, surgical evidence orlookssickANDanyof thebelow apply: Animal history isdocumented, recorded andavailable. ☐ ☐ ☐
and withholdingtime administration, duration oftherapy label information for dose,route of approved drug–ANDfollowed drug non-lactatinglactating/ animal Single drugadministration of status, e.g.lactating Drug not approved for animal without veterinary oversight Multiple drugadministrations the numberofsamplesto becollected. years for whichdata hasbeenreleased. cowsin market duringthemost dairy recent three 27 percent declinein thenumberoftissueresidues Despite thesechanges, USDA FSIS hasreported a number oftests conducted cows. on market dairy sensitive thanearlier tests, and2)increasing ofthe implementation oftheKIStest, whichismore to its residue screening program including:1) past several years, USDA hasmade several changes percentage tests positivefor aresidue. Overthe slaughtered for small beef. avery Ofthat amount, Each year, cows are nearly 3millionadultdairy shouldbewithheldfrom market.in ananimal,they is anydoubt aboutthepotential for drugresidues in assessinganimalsdestined for slaughter. Ifthere of residues are found inFigure 2andcan beuseful for testing. Factors that can contribute to higherrisk injection site lesionsorsignsofillnessare targeted drug residues. Animalsthat displaylameness, facilities identifiestheanimalsmost likely to have Point (HACCP) program implemented at slaughter The USDA FSIS Hazard AnalysisandCritical Control See Figure 3onPage 14. ☐ ☐ ☐
Duration oftherapy not followed followed orunknown Doses orwithholdingtimesnot
drugs inanextra-label manner Veterinary oversight oftheuse 3 TETRACYCLINE TESTING Details on a new residue screening program Starting July 1, government regulators will test bulk milk tankers for the tetracycline family of drugs. This is in addition to current beta-lactam testing already being done. Nearly all dairy farms will have their milk tested for tetracyclines.
WHAT IS CONSIDERED A OXYTETRACYCLINE TETRACYCLINE CHLORTETRACYCLINE TETRACYCLINE? =
WHAT DO YOU NEED TO KNOW COMMON TETRACYCLINE ABOUT TETRACYCLINE USE ? USES ON THE FARM
OXYTETRACYCLINE Establish a Veterinarian-Client-Patient-Relationship. Approved by FDA for use in lactating dairy cattle for treatment of 1 pneumonia, shipping fever, bacterial scours, metritis and topical With your veterinarian, develop a herd health plan for treatment for certain eye infections like pink eye. disease prevention and disease treatment protocols including the use of antibiotics. REMEMBER: No tetracycline family 2 drugs are approved for intramammary Work with your veterinarian and hoof trimmer to use for treating mastitis, without a develop a treatment protocol, including dose and veterinarian’s prescription. withdrawal times for meat and milk if using tetracycline 3 powder for digital dermatitis treatment. Use over-the-counter drugs according to the TETRACYCLINE POWDER manufacturers’ directions, including the specific Administered topically to the hoof with a wrap to treat digital disease condition being treated, amount, route of dermatitis. Treatment can create residues in the milk and teats can adminstration, length of treatment, and meat and become contaminated. Applying 2 grams or less of powder per 4 milk withdrawal times. Any deviation from the label hoof lesion for a maximum of two lesions per cow is enough to directions requires a veterinarian’s prescription. successfully treat the lesion, and is less likely to cause violative residues in cows. REMEMBER: No tetracycline powder is approved for use in lactating dairy cattle for treatment of digital dermatitis without a veterinarian’s prescription.
WHAT HAPPENS IF MILK IS POSTIVE FOR A TETRACYCLINE RESIDUE? STOP If a bulk milk tanker is found to have a tetracycline residue, a traceback to confirm the dairy farm of origin will occur – just as with beta-lactam residue testing. The offending farm will be responsible for the value of the dumped milk and may temporarily lose its milk license.
It is the responsibility of every dairy farmer to ensure that antibiotic residues do not end up in milk offered for sale. Our customers trust the safety of milk because of your commitment to produce a safe and nutritious product. Contact your milk cooperative or processor if you are concerned about a residue in your milk. When in doubt, keep it out! June 2017 Dairy farmers transition their cows from a supplier processing facility or in separate facilities. This list of milk to a source of beef when the decision is is intended to aid inspectors in discovering residue made to ship a cow to market. Shipping sound tolerance violations before they reach consumers. animals reduces the chance that an animal will be The USDA FSIS provides a user guide that explains targeted for drug residue testing. The risk of tissue the information contained in the list. residue violations should be minimized if treatment protocols and appropriate withdrawal times are The USDA FSIS also maintains a “Residue Repeat carefully followed and approved animal drugs Violator List for Use by Livestock Markets and are used for the class of animal being treated. If Establishments” that contains similar information treatment records are well maintained and proper intended to assist plant owners and operators in doses, routes and frequencies of administration are identifying residue history of livestock suppliers. heeded, the risk of violative tissue residues will be This second list documents only the source name minimized. and address information of repeat violators, so that livestock marketers and buyers may use precaution The USDA FSIS maintains a “Residue Repeat when marketing and processing animals from Violator List for Use by FSIS Inspection Personnel” listed suppliers. that contains the names and addresses of producers who have more than one meat The regulatory tolerances for milk and meat residue violation in a 12-month period in animals antibiotic residues vary depending on the type presented for slaughter. Specific information about of drug used and route of administration. The the violation can also be found in this list, including withdrawal times and tolerances are only valid if a the plant where the violation was determined, the drug is used according to the label directions AND drug residues identified, and their concentrations in the class of animal listed on the label. If a drug and tolerances. Violators listed may have had is used in a class of animal NOT on the label, then multiple violations documented in the same there is NO TOLERANCE established for that drug
Figure 3. Yearly Dairy Cull Cow Tissue Residue Violation (April 1st – March 31st)
14 Drug Residue Prevention Reference Manual 2018 and any trace amount, even if it is below the target References testing/tolerance level established for the labeled 1 National Milk Drug Residue Data Base: Fiscal Year 1996 class, is a violation. All of these products have a Annual Report. GLH, Incorporated. Lighthouse, FL. February tolerance limit if it is used in the labeled class of 10, 1997. https://www.kandc-sbcc.com/nmdrd/fy-96.pdf animal. Extra-label drug use in unapproved classes 2 National Milk Drug Residue Data Base: Fiscal Year 2016 of animals is discouraged. A complete list of the Annual Report. GLH, Incorporated. Lighthouse, FL. February 14, 2017. https://www.kandc-sbcc.com/nmdrd/fy-16.pdf tolerances can be found in the FDA Green Book, which lists all approved animal drugs. The Green 3 2017 FSIS National Residue Program Scheduled Sampling Plans. USDA Food Safety Inspection Service Office of Book is available in searchable format online. Public Health Science. June 2017. https://www.fsis.usda. gov/wps/wcm/connect/1808d9c3-414f-4019-a31c- 8454854ab66e/2017-Blue-Book.pdf?MOD=AJPERES When there is doubt about an animal’s drug residue status it is advised to consult experts that 4 U.S. National Residue Program: Residue Quarterly Reports. USDA Food Safety Inspection Service. https://tinyurl.com/ can help determine the status of the drug in the juzwflg animal before it is sent to slaughter. Your herd health veterinarian is a good first resource. The • FDA Green Book, for tissue residue thresholds veterinarian can help determine if pharmaceutical http://www.fda.gov/AnimalVeterinary/Products/ companies should be consulted or live animal ApprovedAnimalDrugProducts/ screening tests employed to determine an animal • FSIS Residue Repeat Violator Lists https://www.fsis.usda. drug residue status. If you have questions or gov/wps/portal/fsis/topics/data-collection-and-reports/ chemistry/residue-chemistry concerns about potential residues or withdrawal • Food Animal Residue Avoidance & Depletion Program times, please contact your herd veterinarian. For (FARAD) http://www.farad.org additional help or information, the following phone • Animal Drugs @ FDA, FDA Approved Animal Drug Products numbers and websites of pharmaceutical and http://www.fda.gov/AnimalVeterinary/Products/ screening test manufacturers may also help with ApprovedAnimalDrugProducts/ advice and determine residue status.
Charm Sciences, Inc. • 1-800-343-2170 www.charm.com Merck’s Dairy Cares 365 • 1-800-521-5767 https://www.dairycare365.com/solution/ residue-prevention-education Zoetis • 1-800-366-5288 www.avoidresidues.com
Chapter 1 Introduction 15 Conditions that Warrant Additional Additionally, inspectors are aware of common Testing at USDA Slaughter Facilities industry practices that could indicate an animal The following list contains descriptions, directly was recently treated. Dairy cows arriving for from USDA documents, of conditions that may slaughter with fetlock or ankle bands indicate that warrant testing of carcasses for drug residues: the animal has previously received treatment for a medical condition. When observed, inspectors • Mastitis Signs of mastitis can vary based on the are instructed to determine the appropriateness of severity and duration of infection and may exhibit additional testing or removal from the food supply. varying degrees of clinical signs, from pus-like or discolored discharge from the teats and redness and swelling of the udder, to no visible change in Food Animal Residue the udder. Avoidance Databank (FARAD) • Metritis USDA inspectors will look for this post- mortem indication. Be mindful of sending animals FARAD is a congressionally-mandated risk- to slaughter that show signs of metritis such as management program that is supported by high fever, major drops in milk production, eye or the USDA. The primary mission of FARAD is to nasal discharge. provide science-based expert advice to help • Peritonitis and Surgery Signs of recent surgical procedures or findings of surgical devices (e.g., mitigate unsafe chemical residues (drugs, suture, toggles, fistula devices) are only significant pesticides, biotoxins, etc.) in products derived if they are associated with active peritoneal or from food animals. subcutaneous inflammation. • Injection Sites Live animals and carcasses with FARAD provides the following services: lesions or abscesses associated with injections on any part of the animal are of potential concern. • Advice on residue avoidance or mitigation • Other Disease Symptoms Any signs of the • VetGram search for required withdrawal following diseases or conditions can lead to times for approved food animal drugs an animal being tested for potential chemical • FARAD-recommended withdrawal residues or to determine fitness for harvest: intervals for extra-label use of approved depression, an elevated or subnormal body food animal drugs temperature, hyperemic skin, congested mucous Producers should work with the veterinarian membranes, dehydration, or poor body condition in association with an injury or inflammatory with whom they have a valid VCPR for drug condition, such as abscesses, arthritis, pneumonia, residue information first. The veterinarian is mastitis, metritis or diamond skin. the ideal resource to discuss FARAD-specific • Signs of Treatment Signs of treatment, information regarding withdrawal times, as indicated by leakage around jugular especially for extra-label drug use. veins, subcutaneously, intramuscularly or intraperitoneally, or clinical signs indicative of treatment by mouth, such as discoloration from particles found in any part of the digestive tract, Visit are important signs when examining veal calves WWW.FARAD.ORG for testing. for more information
16 Drug Residue Prevention Reference Manual 2018 Records Management FDA requires veterinarians to maintain records for two years on all animals treated using extra-label drugs (21 CFR 530.5)4. Though not a regulatory requirement, a good management practice for producers is to keep records on all animals treated with drugs for two years. The record system should be easily accessible to everyone who works with the animals. Records should be permanent so the veterinarian has a history to which he/she can refer to prescribe effective therapy and to serve as protection in case of regulatory follow-up. The producer needs to show how all drugs purchased were used or disposed.
The treatment record should contain the following basic information: • Treatment date • Animal identification • Dosage • Route of administration and expected duration • Withdrawal time for milk and meat • Individual who administered the drug • Drug used • Duration of therapy
Code of Federal Regulations 21 CFR 530.5. Food and Drug Administration. April 1, 2017. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=530.5